HR 1691 · 118th Congress 2023–2025, ended

Ensuring Patient Access to Critical Breakthrough Products Act of 2024

Latest action · Dec 24, 2024 Placed on the Union Calendar, Calendar No. 801.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMar 22, 2023
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Ensuring Patient Access to Critical Breakthrough Products Act of 2023

This bill provides for Medicare coverage of medical devices that are approved under the Food and Drug Administration (FDA) Breakthrough Devices Program. (Under the program, manufacturers work with the FDA to expedite the review and approval of certain medical devices that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating human diseases or conditions.)

The bill allows designated medical breakthrough devices to be temporarily covered under Medicare during a four-year transitional period. The Centers for Medicare & Medicaid Services (CMS) must assign payment codes for such devices within three months of FDA approval. The CMS must also establish a process to allow for continued coverage after the transitional period has expired, taking into account any additional evidence or data the CMS deems necessary.

The CMS must also provide for temporary and, where appropriate, permanent Medicare coverage of breakthrough devices for which there is no existing benefit category (i.e., classification).

Cosponsors 89

Members who signed on, in the order they did. Signatures ran from Mar 22, 2023 to Nov 19, 2024; 7 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-CAAnna G. EshooOriginalMar 22, 2023
R-UTBlake D. MooreOriginalMar 22, 2023
R-KYBrett GuthrieOriginalMar 22, 2023
R-FLGus M. BilirakisOriginalMar 22, 2023
D-WASuzan K. DelBeneOriginalMar 22, 2023
D-ALTerri A. SewellOriginalMar 22, 2023
D-CATony CárdenasOriginalMar 22, 2023
D-MNAngie CraigApr 19, 2023
D-NHAnn M. KusterApr 19, 2023
R-WVCarol D. MillerApr 19, 2023
D-PAChrissy HoulahanApr 19, 2023
R-TXDan CrenshawApr 19, 2023
D-WADerek KilmerApr 19, 2023
R-NEDon BaconApr 19, 2023
D-MAJake AuchinclossApr 19, 2023

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseWays and Means Committee
Referred Mar 22, 2023Markup Jun 27, 2024Reported Dec 24, 2024
HouseEnergy and Commerce Committee
Referred Mar 22, 2023Discharged Dec 24, 2024
Health Subcommittee
Referred Mar 31, 2023Markup Nov 15, 2023Reported Nov 15, 2023

Actions 10

Everything that happened, newest first.

  1. Dec 24, 2024Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-952, Part I.
  2. Dec 24, 2024Committee on Energy and Commerce discharged.
  3. Dec 24, 2024Placed on the Union Calendar, Calendar No. 801.
  4. Jun 27, 2024Committee Consideration and Mark-up Session Held
  5. Jun 27, 2024Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 36 - 5.
  6. Nov 15, 2023Subcommittee Consideration and Mark-up Session Held
  7. Nov 15, 2023Forwarded by Subcommittee to Full Committee by the Yeas and Nays: 21 - 6.
  8. Mar 31, 2023Referred to the Subcommittee on Health.
  9. Mar 22, 2023Introduced in House
  10. Mar 22, 2023Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Committee report

Congressional Budget Office cost estimate

  1. Nov 18, 2024H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023As ordered reported by the House Committee on Ways and Means on June 27, 2024

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article 1, Section 8 The single subject of this legislation is: Health

The sponsor’s statement, as printed in the Congressional Record, vol. 169, no. 52, March 22, 2023, page H1327.

Printed hearings 2

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
Serial No. 118-040BURDENSOME REGULATIONS: EXAMINING THE IMPACT OF EPA REGULATIONS ON MAIN STREET812 pagesSmall Business CommitteeFeb 14, 2024
Serial No. 118-56INNOVATION SAVES LIVES: EVALUATING MEDICARE COVERAGE PATHWAYS FOR INNOVATIVE DRUGS, MEDICAL DEVICES, AND TECHNOLOGY191 pagesEnergy and Commerce CommitteeJul 18, 2023

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 5349Ensuring Patient Access to Critical Breakthrough Products Act of 2024Related billNov 20, 2024

Titles 3

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend title XVIII of the Social Security Act to ensure prompt coverage of breakthrough devices under the Medicare program, and for other purposes.
Short Title(s) as Introduced
Ensuring Patient Access to Critical Breakthrough Products Act of 2023
Short Title(s) as Reported to House
Ensuring Patient Access to Critical Breakthrough Products Act of 2024

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 2

Each version as it was printed, newest first.

  1. Dec 24, 2024Reported in House
  2. Mar 22, 2023Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.